BMI Alternative Could Change Obesity Diagnoses for Millions, Study Finds

Why BMI Is Being Reconsidered

A study reported by STAT and The Guardian suggests that using an alternative to body mass index, or BMI, could change obesity classifications for millions of people. The proposed approach is intended to assess body fat and health more directly, potentially reducing misclassification caused by relying on height and weight alone. Source 1 Source 5

The issue matters because an obesity classification can influence clinical discussions, treatment decisions, insurance processes, medical records, and public-health statistics. BMI remains widely used because it is inexpensive, quick, and easy to calculate. However, a ratio based only on height and weight cannot show how much of a person’s weight comes from fat or muscle, where fat is stored, or whether metabolic complications are present.

The study does not establish that BMI will disappear from medical practice immediately. Instead, it adds to a broader debate about whether obesity assessment should combine body composition, fat distribution, laboratory results, physical function, and personal health history.

The available summaries do not provide the study’s full methodology, sample size, formal name of the proposed alternative, exact formula, or precise number of people who would be reclassified. The reliable conclusion is narrower: an alternative measure could change obesity diagnoses for millions, demonstrating how measurement choices can affect medical classification.

What BMI Measures—and What It Misses

BMI estimates body size by dividing weight in kilograms by height in meters squared. Health systems commonly classify results as underweight, healthy weight, overweight, or obesity.

BMI is practical. Clinics do not need specialized equipment to calculate it, and researchers can apply the same formula to large populations. Doctors can also use it as an initial screening measure during routine visits.

Its simplicity creates limitations. BMI does not directly measure fat tissue, lean muscle, bone, or water. Two people with the same height and weight receive the same BMI even when their body composition differs substantially.

BMI may help identify people who need further evaluation, but it is not a complete health assessment. It does not directly measure:

• Body-fat percentage
• Muscle mass
• Fat distribution
• Visceral fat
• Blood pressure
• Blood glucose
• Cholesterol
• Physical function
• Sleep quality
• Mental health
• Existing obesity-related disease

A clinical assessment should therefore consider BMI alongside other information. A person’s risk of diabetes, cardiovascular disease, sleep apnea, joint problems, or reduced mobility cannot be determined from BMI alone.

How BMI Can Misclassify People

BMI can produce false positives. Someone with substantial muscle mass may fall within an obesity category despite having a relatively low body-fat percentage. Athletes and people with highly developed lean tissue are familiar examples, although the same issue can affect others with above-average muscle mass.

BMI can also produce false negatives. Someone may fall below the obesity threshold while carrying a clinically important amount of body fat, particularly around the abdomen. Abdominal or visceral fat can be associated with metabolic risk even when total body weight does not appear unusually high.

Accuracy can vary across age groups, sexes, racial and ethnic populations, body types, and health conditions. Older adults may lose muscle while retaining or gaining fat, causing weight and BMI to understate changes in body composition.

These limitations do not make BMI useless. They show why it should not be interpreted without context.

The Proposed Alternative to BMI

A More Direct Measure of Body Fat and Health

The reported study supports an approach intended to move beyond height and weight alone. The alternative is described broadly as a measure that could assess body fat and health more directly. The available reporting does not identify enough technical detail to name its formal index or explain its exact formula.

At a general level, the approach may incorporate indicators of body fat, fat distribution, or metabolic health. A measure that reflects the amount and location of fat could provide different information from BMI. A measure that also includes health markers could connect an obesity classification more closely to actual medical risk.

The goal is not to make diagnosis more complicated for its own sake. It is to reduce the gap between a numerical category and a person’s underlying health status.

How Classifications Could Change

Some people currently classified as having obesity by BMI could fall outside that category under a different assessment. Others who do not meet the BMI threshold could qualify under a measure that detects clinically important body fat or health risk more effectively.

The person’s body has not necessarily changed. The classification changes because the measurement method changes.

Reclassification does not automatically determine whether someone needs treatment, whether a person is healthy, whether weight loss is appropriate, or whether body size caused a particular condition. A more accurate measure should guide further assessment rather than replace clinical judgment.

The key question is whether the alternative identifies meaningful health risks better than BMI. If it changes many labels without improving predictions of disease or treatment needs, its clinical value would remain uncertain.

Diagnosis Versus Risk Assessment

An obesity label is a classification, not a complete risk assessment. Risks such as diabetes, cardiovascular disease, sleep apnea, joint disease, liver disease, and reduced physical function should be evaluated through relevant measurements and medical history.

Blood pressure, glucose regulation, lipid levels, waist size, family history, sleep symptoms, medications, and activity level may all contribute to the assessment. The strongest approach may not be a single replacement number, but a group of measurements that describes body composition and connects it with measurable outcomes.

Why Misclassification Matters

An inaccurate obesity classification can contribute to stigma and affect how clinicians interpret a patient’s symptoms. A person may receive weight-loss advice when the immediate medical issue requires a different evaluation. A high BMI can also lead to assumptions about diet, behavior, motivation, or lifestyle that are not supported by the patient’s history.

Diagnostic labels may affect medical records, insurance processes, eligibility assessments, and access to services. If a label is based on an incomplete measure, those systems may reproduce the same error.

The opposite error can also be harmful. Someone whose BMI falls below the obesity threshold may not receive an appropriate assessment of abdominal fat, blood glucose, blood pressure, or cholesterol. Metabolic risk can exist across a range of body sizes.

Clinicians may need to consider:

• Waist or abdominal measurements
• Body composition
• Blood pressure
• Blood glucose and other measures of glucose regulation
• Lipid levels
• Family history
• Physical activity and function
• Sleep symptoms
• Existing medical conditions

A normal or moderately elevated BMI should not end a risk assessment when other signs suggest possible health problems.

Effects on Public-Health Statistics

Changing the way obesity is measured could alter prevalence estimates and health trend reports. A population could appear to have more or fewer cases of obesity even if its underlying health had not changed at the same rate.

The change could affect research comparisons, resource allocation, public-health planning, and estimates of demand for obesity services. Researchers would need to explain whether a change in reported prevalence reflects a real change in health or a revised definition.

The Case for Moving Beyond BMI Alone

A broader assessment could help clinicians identify excess body fat more accurately and recognize risks that BMI misses. It could reduce reliance on a single category and support treatment plans based on blood pressure, glucose, mobility, sleep, pain, cardiovascular risk, and patient goals.

Body size and health are related, but they are not interchangeable. A person’s weight can be clinically relevant without explaining every aspect of that person’s health.

Potential tools include waist measurements, body-composition testing, clinical examination, laboratory tests, and health-history reviews. These methods differ in accuracy, cost, and availability. A more detailed assessment should be used when it can improve decisions, not as an automatic requirement for every patient.

Obesity risk often exists along a spectrum rather than changing abruptly at one threshold. Someone just below a BMI cutoff may have similar metabolic risk to someone just above it. Conversely, two people above the same cutoff may have very different health profiles.

A more nuanced approach would consider:

• Metabolic health
• Mobility and physical function
• Sleep
• Mental health
• Existing diagnoses
• Medication use
• Quality of life
• Patient priorities

The aim should be more accurate care and less stigma while preserving access to effective treatment for people who need it.

Limits and Unanswered Questions

The available summaries do not provide the study’s full design, study population, formal alternative measurement, exact number of people reclassified, follow-up period, or clinical outcomes used for validation. They also do not establish whether the findings have been independently replicated.

Those details matter before medical organizations change guidelines. A measure can be scientifically interesting but difficult to use in routine care. It can also produce different classifications without offering better predictions of disease.

Does the Alternative Predict Health Outcomes Better?

The central validation question is whether the alternative predicts outcomes more accurately than BMI. Relevant outcomes could include diabetes, cardiovascular disease, disability, mortality, sleep apnea, and other clinically important conditions.

Researchers should compare the proposed method with BMI, waist circumference, body-fat percentage, metabolic markers, and combined risk models. The key test is clinical usefulness, not merely how many diagnoses change.

Accessibility, Cost, and Standardization

Some body-composition technologies are expensive or unavailable in primary-care settings. Results can vary by device, operator, hydration status, and testing protocol. Waist measurements are inexpensive but require consistent technique. New formulas may also be difficult to integrate into electronic records or insurance systems.

Any replacement or supplement must be accurate, affordable, reproducible, understandable, and practical. It should also work across diverse populations and health systems.

Replacing BMI with one new score could repeat the same problem if clinicians treat that score as a complete definition of health. A layered process may work better:

1. Initial screening
2. Assessment of body composition or fat distribution when appropriate
3. Metabolic testing
4. Review of medical and family history
5. Shared decision-making about treatment

What This Could Mean for Patients

A study about population-level classification does not independently diagnose any individual. Patients should not start or stop treatment based only on a news report, online calculator, or unverified interpretation of a new measure.

People concerned about BMI or body composition should discuss the issue with a qualified health professional. The relevant question is not only which category applies, but what the available evidence says about the person’s health and treatment goals.

Patients may ask:

• Which measurements are being used to assess my health?
• Does my BMI reflect my body composition accurately?
• Should waist circumference or another body-fat measure be considered?
• What do my blood pressure, glucose, and cholesterol results show?
• What health outcomes should treatment focus on?
• How will the plan account for my goals, preferences, and existing conditions?

Useful measures of progress may include improved blood sugar, better blood-pressure control, improved sleep, greater mobility, reduced pain, better cardiovascular fitness, and improved quality of life.

Weight can be one health factor without being the only measure of progress. A patient-centered plan should evaluate outcomes that matter to the person’s health and daily life.

Broader Context: Obesity Care Is Becoming More Complex

Obesity care increasingly includes lifestyle support, behavioral interventions, medical treatment, surgery for eligible patients, and management of related conditions. As treatment options expand, accurate assessment becomes more important. Clinicians need to identify who may benefit, which risks require attention, and which outcomes should be monitored.

Related research also challenges weight-centered assumptions. One reported study found that prediabetes could improve without weight loss, suggesting that better blood-sugar health is not always dependent on losing weight. Source 9

That finding does not make weight irrelevant. Weight loss can benefit some people, and body fat can influence health. The broader lesson is that assessment should measure actual health outcomes rather than use weight as a universal proxy for metabolic health.

What Could Change in Clinical Practice

A practical transition could retain BMI for basic screening while adding information about fat distribution, body composition, metabolic markers, and individual characteristics. This would preserve BMI’s affordability while reducing reliance on it as a stand-alone diagnosis.

The available reporting does not show that medical organizations have already adopted the proposed alternative. Professional organizations would need to evaluate accuracy, predictive value, safety, equity, cost, and feasibility. Guideline changes generally require replication, expert review, and evidence that the new approach improves patient care.

The study is therefore a reason for further evaluation, not proof that BMI should be abandoned immediately.

A new measure could reduce disparities if BMI currently misclassifies particular populations. It could also create new disparities if it depends on costly equipment, lacks validation across diverse groups, or is unavailable in under-resourced clinics. Researchers should test the approach across age groups, sexes, racial and ethnic populations, body types, and health conditions.

Conclusion

The reported study suggests that an alternative to BMI could change obesity classifications for millions of people. The finding highlights a basic limitation of BMI: it is a convenient screening tool, but it does not directly measure body fat, fat distribution, metabolic health, or overall well-being.

A better approach would combine body composition, abdominal fat, laboratory results, physical function, medical history, and patient goals. BMI should be treated as one data point rather than a complete diagnosis.

The supplied reporting does not establish that the proposed alternative is ready to replace BMI everywhere. More information is needed about its formula, validation, cost, accessibility, and performance across diverse populations.

For patients, the central message is simple: a classification is not the same as a complete health assessment. Better diagnosis should reduce misclassification, support appropriate care, and focus on health outcomes rather than a single number.

Frequently Asked Questions

Is BMI still useful?

Yes. BMI can remain useful as a quick screening tool in clinical and public-health settings. It should not be treated as a complete assessment of body fat or health risk.

What could replace BMI?

The reported study discusses an alternative intended to assess body fat and health more directly. The available summaries do not identify its formal name or provide enough technical detail to describe its exact formula.

A practical assessment may combine body composition, waist or fat distribution, metabolic markers, and clinical history.

Can someone have obesity-related health risks without a high BMI?

Yes. BMI may miss people who carry significant abdominal or total body fat while remaining below an obesity threshold. Blood pressure, blood glucose, cholesterol, family history, and fat distribution can provide additional information.

Can someone have a high BMI without excess body fat?

Yes. People with substantial muscle mass may have a high BMI without having the level of body fat implied by the category. Body-composition and clinical measurements can provide a clearer assessment.

Does reclassification mean that a person’s health has changed?

No. Reclassification reflects a change in the measurement method, not necessarily a change in the person’s body or health. Treatment decisions should use validated risk factors, symptoms, health goals, and clinical evaluation.

Should people stop using BMI now?

No. The study supports examining BMI’s limitations, not making unsupervised changes to diagnosis or treatment. Patients should discuss alternative measurements and individual risks with a qualified health professional.